OncoSeer Diagnostics
Core Members
OncoSeer Diagnostics, Inc. is a biotech startup developing novel diagnostic biomarkers for use by oncologists and drug companies to predict immune related adverse events (irAE's) from immune checkpoint inhibitors (ICI's). OncoSeer Diagnostics, Inc. (OncoSeer), a collaboration with UT Southwestern Medical Center (UTSW), is developing multimarker blood tests that diagnose and predict immune related adverse events (irAE) in oncology patients undergoing immune checkpoint inhibitor (ICI) therapy. Core Membership
OncoSeer Diagnostics
Categories
About
Membership Type